STAT2 and hepatocellular carcinoma: Previous studies have suggested that IFIT3 enhances the interferon (IFN) effector signaling pathway by promoting the formation and nuclear localization of the STAT1-STAT2 heterodimer in hepatocellular carcinoma (57).